Evidence map›Paper›PMID 30735313›Full record

ArticleCurrent protocols in molecular biology2019

Higher Mass Accuracy MALDI-TOF/TOF Lipid Imaging of Human Brain Tissue in Alzheimer's Disease.

Matthew B O'Rourke, Caine C Smith, Suzanne M De La Monte, Greg T Sutherland, Matthew P Padula

Abstract read
In one paragraph

Article in Current protocols in molecular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matthew B O'RourkeSydney Mass Spectrometry, Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales, Australia.
Caine C SmithNeuropathology Group, Discipline of Pathology, School of Medical Sciences and Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.
Suzanne M De La MonteDepartment of Pathology, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, Rhode Island.
Greg T SutherlandNeuropathology Group, Discipline of Pathology, School of Medical Sciences and Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.
Matthew P PadulaProteomics Core Facility, University of Technology Sydney, Ultimo, New South Wales, Australia.

Funding

FASD Inhibition of ASPH-Notch Mediates Adolescent Cerebral White Matter Pathology-Potential Utility of Non-invasive Extracellular Vesicle AssaysR01AA011431 · NIAAA · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI SUZANNE M. DE LA MONTE · 1996 to 2026
$5.4M
BRAIN TISSUE RESOURCE CENTER FOR ALCOHOL RESEARCHR24AA012725 · NIAAA · UNIVERSITY OF SYDNEY · PI KRIL, JILLIAN JUNE · 2000 to 2011
$2.2M
Pathogenesis of Early- Versus Late-Stage Alcohol-Mediated White Matter DegenerationR01AA028408 · NIAAA · RHODE ISLAND HOSPITAL · PI DE LA MONTE, SUZANNE M. · 2021 to 2025
$1.7M
NIAAA NIH HHS R01 AA011431NIAAA NIH HHS R01 AA028408NIAAA NIH HHS R24 AA012725
6 · The paper itself

Abstract

Matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDI-IMS) is a well-established technique for elucidating the location and relative abundance of a range of biomolecules. More recently, research into this technique has shifted from simple discovery and demonstration of utility to application in biomedical research. Here, we describe a protocol utilizing MALDI-IMS for the spatial mapping of lipids in brain tissue from normal human brains and brains from patients with Alzheimer's disease, in the context of Alzheimer's disease. Improved accuracy calibration of the instrument from the tissue surface is emphasized, as this allows for significantly improved mass determination in time of flight (TOF)-based instruments enabling more confident preliminary lipid identification. This improved initial result allows MALDI-IMS data to be complemented with additional instrumentation, such as liquid chromatography mass spectrometry workflows or specialized non-TOF systems such as Fourier transform cyclotron resonance instruments. This method is not limited to human tissue and can be applied to virtually any lipid-rich formalin-fixed tissue. © 2019 by John Wiley & Sons, Inc.

Indexed as

Brain ChemistryAlzheimer DiseaseBrainHumansLipidsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationLipidsIMSlipid imagingMALDI imagingsublimation

Identifiers

PMID30735313
PMCPMC10867813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.